遗传性血管性水肿患者血管性水肿发作的触发因素和前驱症状 - Suppr

Triggers and Prodromal Symptoms of Angioedema Attacks in Patients With Hereditary Angioedema.

作者信息

Caballero T, Maurer M, Longhurst H J, Aberer W, Bouillet L, Fabien V

机构信息

Allergy Department, Hospital La Paz Institute for Health Research (IdiPaz), Biomedical Research Network on Rare Diseases (CIBERER, U754), Madrid, Spain.

Department of Dermatology and Allergy, Allergie-Centrum- Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany.

出版信息

J Investig Allergol Clin Immunol. 2016;26(6):383-386. doi: 10.18176/jiaci.0102.

DOI:10.18176/jiaci.0102

PMID:27996949

Abstract

摘要

相似文献

Triggers and Prodromal Symptoms of Angioedema Attacks in Patients With Hereditary Angioedema.

J Investig Allergol Clin Immunol. 2016;26(6):383-386. doi: 10.18176/jiaci.0102.

Treatment of hereditary angioedema with icatibant: efficacy in clinical trials versus effectiveness in the real-world setting.

Allergy Asthma Proc. 2014 Sep-Oct;35(5):377-81. doi: 10.2500/aap.2014.35.3780. Epub 2014 Aug 6.

Bradykinin B2 receptor antagonist off label use in short-term prophylaxis in hereditary angioedema.

Int J Immunopathol Pharmacol. 2014 Oct-Dec;27(4):653-9. doi: 10.1177/039463201402700423.

Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report.

Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1):269-73. doi: 10.1177/039463201202500130.

Icatibant for Multiple Hereditary Angioedema Attacks across the Controlled and Open-Label Extension Phases of FAST-3.

Int Arch Allergy Immunol. 2015;168(1):44-55. doi: 10.1159/000441060. Epub 2015 Nov 11.

The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries.

J Eur Acad Dermatol Venereol. 2017 Jul;31(7):1214-1222. doi: 10.1111/jdv.14251. Epub 2017 Jun 1.

Icatibant as acute treatment for hereditary angioedema in adults.

Expert Rev Clin Pharmacol. 2016 Jun;9(6):779-88. doi: 10.1080/17512433.2016.1182425. Epub 2016 May 13.

Pediatricians diagnosed few patients with childhood-presented hereditary angioedema: Icatibant Outcome Survey findings.

J Allergy Clin Immunol Pract. 2019 Mar;7(3):1078-1080. doi: 10.1016/j.jaip.2018.07.047. Epub 2018 Aug 28.

Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study.

Allergy. 2013 Nov;68(11):1452-9. doi: 10.1111/all.12244. Epub 2013 Sep 21.

Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study.

Sao Paulo Med J. 2014;132(5):261-5. doi: 10.1590/1516-3180.2014.1325652. Epub 2014 Jul 22.

引用本文的文献

Attack frequency and associated factors in hereditary angioedema patients: a single-centre experience.

Postepy Dermatol Alergol. 2025 Feb;42(1):75-82. doi: 10.5114/ada.2024.144488. Epub 2024 Nov 6.

Hereditary angioedema diagnosis evaluation score (HADES): A new clinical scoring system for predicting hereditary angioedema with C1 inhibitor deficiency.

J Allergy Clin Immunol Glob. 2025 Jan 17;4(2):100414. doi: 10.1016/j.jacig.2025.100414. eCollection 2025 May.

A real-world study of hereditary angioedema patients due to C1 inhibitor deficiency treated with danazol in the Brazilian Public Health System.

Front Med (Lausanne). 2024 Sep 6;11:1343547. doi: 10.3389/fmed.2024.1343547. eCollection 2024.

Case Report: Early presentation of hereditary angioedema symptoms in a 2-year-old boy.

Front Pediatr. 2024 Jun 24;12:1408110. doi: 10.3389/fped.2024.1408110. eCollection 2024.

Mast cell degranulation and bradykinin-induced angioedema - searching for the missing link.

Front Immunol. 2024 May 15;15:1399459. doi: 10.3389/fimmu.2024.1399459. eCollection 2024.

[Hereditary angioedema due to C1-inhibitor deficiency, a national disease management programme].

Wien Klin Wochenschr. 2023 Nov;135(Suppl 8):785-798. doi: 10.1007/s00508-023-02298-x. Epub 2023 Dec 8.

The multifactorial impact of receiving a hereditary angioedema diagnosis.

World Allergy Organ J. 2023 Jun 30;16(6):100792. doi: 10.1016/j.waojou.2023.100792. eCollection 2023 Jun.

Managing Diagnosis, Treatment, and Burden of Disease in Hereditary Angioedema Patients with Normal C1-Esterase Inhibitor.

J Asthma Allergy. 2023 Apr 22;16:447-460. doi: 10.2147/JAA.S398333. eCollection 2023.

Content validation and psychometric evaluation of the Angioedema Quality of Life Questionnaire for hereditary angioedema.

J Patient Rep Outcomes. 2023 Apr 3;7(1):33. doi: 10.1186/s41687-023-00576-w.

Hereditary Angioedema: The Clinical Picture of Excessive Contact Activation.

Semin Thromb Hemost. 2024 Oct;50(7):978-988. doi: 10.1055/s-0042-1758820. Epub 2022 Nov 23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Triggers and Prodromal Symptoms of Angioedema Attacks in Patients With Hereditary Angioedema.

作者信息

Caballero T, Maurer M, Longhurst H J, Aberer W, Bouillet L, Fabien V

机构信息

Allergy Department, Hospital La Paz Institute for Health Research (IdiPaz), Biomedical Research Network on Rare Diseases (CIBERER, U754), Madrid, Spain.

Department of Dermatology and Allergy, Allergie-Centrum- Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany.

出版信息

J Investig Allergol Clin Immunol. 2016;26(6):383-386. doi: 10.18176/jiaci.0102.

DOI:10.18176/jiaci.0102

PMID:27996949

Abstract

摘要

相似文献

Triggers and Prodromal Symptoms of Angioedema Attacks in Patients With Hereditary Angioedema.

J Investig Allergol Clin Immunol. 2016;26(6):383-386. doi: 10.18176/jiaci.0102.

Treatment of hereditary angioedema with icatibant: efficacy in clinical trials versus effectiveness in the real-world setting.

Allergy Asthma Proc. 2014 Sep-Oct;35(5):377-81. doi: 10.2500/aap.2014.35.3780. Epub 2014 Aug 6.

Bradykinin B2 receptor antagonist off label use in short-term prophylaxis in hereditary angioedema.

Int J Immunopathol Pharmacol. 2014 Oct-Dec;27(4):653-9. doi: 10.1177/039463201402700423.

Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report.

Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1):269-73. doi: 10.1177/039463201202500130.

Icatibant for Multiple Hereditary Angioedema Attacks across the Controlled and Open-Label Extension Phases of FAST-3.

Int Arch Allergy Immunol. 2015;168(1):44-55. doi: 10.1159/000441060. Epub 2015 Nov 11.

The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries.

J Eur Acad Dermatol Venereol. 2017 Jul;31(7):1214-1222. doi: 10.1111/jdv.14251. Epub 2017 Jun 1.

Icatibant as acute treatment for hereditary angioedema in adults.

Expert Rev Clin Pharmacol. 2016 Jun;9(6):779-88. doi: 10.1080/17512433.2016.1182425. Epub 2016 May 13.

Pediatricians diagnosed few patients with childhood-presented hereditary angioedema: Icatibant Outcome Survey findings.

J Allergy Clin Immunol Pract. 2019 Mar;7(3):1078-1080. doi: 10.1016/j.jaip.2018.07.047. Epub 2018 Aug 28.

Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study.

Allergy. 2013 Nov;68(11):1452-9. doi: 10.1111/all.12244. Epub 2013 Sep 21.

Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study.

Sao Paulo Med J. 2014;132(5):261-5. doi: 10.1590/1516-3180.2014.1325652. Epub 2014 Jul 22.

引用本文的文献

Attack frequency and associated factors in hereditary angioedema patients: a single-centre experience.

Postepy Dermatol Alergol. 2025 Feb;42(1):75-82. doi: 10.5114/ada.2024.144488. Epub 2024 Nov 6.

Hereditary angioedema diagnosis evaluation score (HADES): A new clinical scoring system for predicting hereditary angioedema with C1 inhibitor deficiency.

J Allergy Clin Immunol Glob. 2025 Jan 17;4(2):100414. doi: 10.1016/j.jacig.2025.100414. eCollection 2025 May.

A real-world study of hereditary angioedema patients due to C1 inhibitor deficiency treated with danazol in the Brazilian Public Health System.

Front Med (Lausanne). 2024 Sep 6;11:1343547. doi: 10.3389/fmed.2024.1343547. eCollection 2024.

Case Report: Early presentation of hereditary angioedema symptoms in a 2-year-old boy.

Front Pediatr. 2024 Jun 24;12:1408110. doi: 10.3389/fped.2024.1408110. eCollection 2024.

Mast cell degranulation and bradykinin-induced angioedema - searching for the missing link.

Front Immunol. 2024 May 15;15:1399459. doi: 10.3389/fimmu.2024.1399459. eCollection 2024.

[Hereditary angioedema due to C1-inhibitor deficiency, a national disease management programme].

Wien Klin Wochenschr. 2023 Nov;135(Suppl 8):785-798. doi: 10.1007/s00508-023-02298-x. Epub 2023 Dec 8.

The multifactorial impact of receiving a hereditary angioedema diagnosis.

World Allergy Organ J. 2023 Jun 30;16(6):100792. doi: 10.1016/j.waojou.2023.100792. eCollection 2023 Jun.

Managing Diagnosis, Treatment, and Burden of Disease in Hereditary Angioedema Patients with Normal C1-Esterase Inhibitor.

J Asthma Allergy. 2023 Apr 22;16:447-460. doi: 10.2147/JAA.S398333. eCollection 2023.

Content validation and psychometric evaluation of the Angioedema Quality of Life Questionnaire for hereditary angioedema.

J Patient Rep Outcomes. 2023 Apr 3;7(1):33. doi: 10.1186/s41687-023-00576-w.

Hereditary Angioedema: The Clinical Picture of Excessive Contact Activation.

Semin Thromb Hemost. 2024 Oct;50(7):978-988. doi: 10.1055/s-0042-1758820. Epub 2022 Nov 23.

Triggers and Prodromal Symptoms of Angioedema Attacks in Patients With Hereditary Angioedema.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Triggers and Prodromal Symptoms of Angioedema Attacks in Patients With Hereditary Angioedema.

作者信息

机构信息

出版信息

相似文献

引用本文的文献